Intracellular Routing and Recognition of Lipid-Based mRNA Nanoparticles - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Pharmaceutics Année : 2021

Intracellular Routing and Recognition of Lipid-Based mRNA Nanoparticles

Luc Even
  • Fonction : Auteur
Patrick Midoux
Chantal Pichon
Federico Perche

Résumé

Messenger RNA (mRNA) is being extensively used in gene therapy and vaccination due to its safety over DNA, in the following ways: its lack of integration risk, cytoplasmic expression, and transient expression compatible with fine regulations. However, clinical applications of mRNA are limited by its fast degradation by nucleases, and the activation of detrimental immune responses. Advances in mRNA applications, with the recent approval of COVID-19 vaccines, were fueled by optimization of the mRNA sequence and the development of mRNA delivery systems. Although delivery systems and mRNA sequence optimization have been abundantly reviewed, understanding of the intracellular processing of mRNA is mandatory to improve its applications. We will focus on lipid nanoparticles (LNPs) as they are the most advanced nanocarriers for the delivery of mRNA. Here, we will review how mRNA therapeutic potency can be affected by its interactions with cellular proteins and intracellular distribution.
Fichier principal
Vignette du fichier
2021_delehede_perche_pichon_pharmaceutics.pdf (1.49 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03335664 , version 1 (19-11-2021)

Identifiants

Citer

Christophe Delehedde, Luc Even, Patrick Midoux, Chantal Pichon, Federico Perche. Intracellular Routing and Recognition of Lipid-Based mRNA Nanoparticles. Pharmaceutics, 2021, 13 (7), pp.945. ⟨10.3390/pharmaceutics13070945⟩. ⟨hal-03335664⟩
67 Consultations
350 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More